| Effect of catheter ablation vs antiarrhythmic drug therapy on mortality, stroke, bleeding, and cardiac arrest among patients with atrial fibrillation: the CABANA randomized … DL Packer, DB Mark, RA Robb, KH Monahan, TD Bahnson, JE Poole, ... Jama 321 (13), 1261-1274, 2019 | 1241 | 2019 |
| An artificial intelligence-enabled ECG algorithm for the identification of patients with atrial fibrillation during sinus rhythm: a retrospective analysis of outcome prediction ZI Attia, PA Noseworthy, F Lopez-Jimenez, SJ Asirvatham, AJ Deshmukh, ... The Lancet 394 (10201), 861-867, 2019 | 1065 | 2019 |
| Screening for cardiac contractile dysfunction using an artificial intelligence–enabled electrocardiogram ZI Attia, S Kapa, F Lopez-Jimenez, PM McKie, DJ Ladewig, G Satam, ... Nature medicine 25 (1), 70-74, 2019 | 855 | 2019 |
| Non–vitamin K antagonist oral anticoagulant dosing in patients with atrial fibrillation and renal dysfunction X Yao, ND Shah, LR Sangaralingham, BJ Gersh, PA Noseworthy Journal of the American College of Cardiology 69 (23), 2779-2790, 2017 | 515 | 2017 |
| Common variants at ten loci influence QT interval duration in the QTGEN Study C Newton-Cheh, M Eijgelsheim, KM Rice, PIW De Bakker, X Yin, ... Nature genetics 41 (4), 399-406, 2009 | 513 | 2009 |
| Urgent guidance for navigating and circumventing the QTc-prolonging and torsadogenic potential of possible pharmacotherapies for coronavirus disease 19 (COVID-19) JR Giudicessi, PA Noseworthy, PA Friedman, MJ Ackerman Mayo Clinic Proceedings 95 (6), 1213-1221, 2020 | 484 | 2020 |
| Outcomes associated with apixaban use in patients with end-stage kidney disease and atrial fibrillation in the United States KC Siontis, X Zhang, A Eckard, N Bhave, DE Schaubel, K He, A Tilea, ... Circulation 138 (15), 1519-1529, 2018 | 479 | 2018 |
| Effectiveness and safety of dabigatran, rivaroxaban, and apixaban versus warfarin in nonvalvular atrial fibrillation X Yao, NS Abraham, LR Sangaralingham, MF Bellolio, RD McBane, ... Journal of the American Heart Association 5 (6), e003725, 2016 | 468 | 2016 |
| Effect of adherence to oral anticoagulants on risk of stroke and major bleeding among patients with atrial fibrillation X Yao, NS Abraham, GC Alexander, W Crown, VM Montori, ... Journal of the American Heart Association 5 (2), e003074, 2016 | 458 | 2016 |
| Artificial intelligence-enhanced electrocardiography in cardiovascular disease management KC Siontis, PA Noseworthy, ZI Attia, PA Friedman Nature Reviews Cardiology 18 (7), 465-478, 2021 | 435 | 2021 |
| QTc prolongation, torsades de pointes, and psychotropic medications SR Beach, CM Celano, PA Noseworthy, JL Januzzi, JC Huffman Psychosomatics 54 (1), 1-13, 2013 | 393 | 2013 |
| Atrial fibrillation burden: moving beyond atrial fibrillation as a binary entity: a scientific statement from the American Heart Association LY Chen, MK Chung, LA Allen, M Ezekowitz, KL Furie, P McCabe, ... Circulation 137 (20), e623-e644, 2018 | 329 | 2018 |
| Genetic association study of QT interval highlights role for calcium signaling pathways in myocardial repolarization DE Arking, SL Pulit, L Crotti, P Van Der Harst, PB Munroe, TT Koopmann, ... Nature genetics 46 (8), 826-836, 2014 | 319 | 2014 |
| Lifestyle and risk factor modification for reduction of atrial fibrillation: a scientific statement from the American Heart Association MK Chung, LL Eckhardt, LY Chen, HM Ahmed, R Gopinathannair, ... Circulation 141 (16), e750-e772, 2020 | 314 | 2020 |
| Direct comparison of dabigatran, rivaroxaban, and apixaban for effectiveness and safety in nonvalvular atrial fibrillation PA Noseworthy, X Yao, NS Abraham, LR Sangaralingham, RD McBane, ... Chest 150 (6), 1302-1312, 2016 | 296 | 2016 |
| Renal outcomes in anticoagulated patients with atrial fibrillation X Yao, N Tangri, BJ Gersh, LR Sangaralingham, ND Shah, KA Nath, ... Journal of the American College of Cardiology 70 (21), 2621-2632, 2017 | 292 | 2017 |
| Age and sex estimation using artificial intelligence from standard 12-lead ECGs ZI Attia, PA Friedman, PA Noseworthy, F Lopez-Jimenez, DJ Ladewig, ... Circulation: Arrhythmia and Electrophysiology 12 (9), e007284, 2019 | 284 | 2019 |
| Ablation versus drug therapy for atrial fibrillation in heart failure: results from the CABANA trial DL Packer, JP Piccini, KH Monahan, HR Al-Khalidi, AP Silverstein, ... Circulation 143 (14), 1377-1390, 2021 | 283 | 2021 |
| Meta-analysis of selective serotonin reuptake inhibitor-associated QTc prolongation SR Beach, WJ Kostis, CM Celano, JL Januzzi, JN Ruskin, PA Noseworthy, ... The Journal of clinical psychiatry 75 (5), 11731, 2014 | 269 | 2014 |
| Guidance for cardiac electrophysiology during the COVID-19 pandemic from the Heart Rhythm Society COVID-19 Task Force; electrophysiology section of the American College of … DR Lakkireddy, MK Chung, R Gopinathannair, KK Patton, TJ Gluckman, ... Circulation 141 (21), e823-e831, 2020 | 263 | 2020 |
